Insights

Early-stage, high potential Target neurologists and memory clinics as primary adopters for the MemorEM device once FDA approval is secured, positioning NeuroEM as a premiere non-drug treatment option for Alzheimer’s and other neurodegenerative conditions.

Clinical leadership Leverage the recent appointment of a Chief Medical Officer to engage clinical thought leaders, build credibility, and accelerate physician referrals, payor discussions, and trial partnerships.

Financing traction Capitalize on recent $5M equity financing to support clinical progression, pilot programs with key hospitals, and early access trials that can generate real-world data and case studies for sales narratives.

Public recognition Utilize Tampa Bay Inno Award exposure and media coverage to open doors with regional health systems, potential distributors, and investor networks that value innovation in healthtech and neurodegenerative care.

Strategic partnerships Propose collaborations with contract research organizations, academic medical centers, and specialty device distributors to expand reach, gather robust clinical evidence, and streamline reimbursement discussions post FDA clearance.

NeuroEM Therapeutics Inc. Tech Stack

NeuroEM Therapeutics Inc. uses 8 technology products and services including Open Graph, Squarespace, Squarespace Commerce, and more. Explore NeuroEM Therapeutics Inc.'s tech stack below.

  • Open Graph
    Content Management System
  • Squarespace
    Content Management System
  • Squarespace Commerce
    E-commerce
  • Font Awesome
    Font Scripts
  • Modernizr
    Javascript Libraries
  • parallax.js
    Javascript Libraries
  • Google Tag Manager
    Tag Management
  • Adobe Fonts
    Web Fonts

Media & News

NeuroEM Therapeutics Inc.'s Email Address Formats

NeuroEM Therapeutics Inc. uses at least 1 format(s):
NeuroEM Therapeutics Inc. Email FormatsExamplePercentage
First.Last@neuroem.comJohn.Doe@neuroem.com
86%
First@neuroem.comJohn@neuroem.com
14%

Frequently Asked Questions

What is NeuroEM Therapeutics Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact NeuroEM Therapeutics Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NeuroEM Therapeutics Inc.'s official website and social media links?

Minus sign iconPlus sign icon
NeuroEM Therapeutics Inc.'s official website is neuroem.com and has social profiles on LinkedIn.

How much revenue does NeuroEM Therapeutics Inc. generate?

Minus sign iconPlus sign icon
As of July 2026, NeuroEM Therapeutics Inc.'s annual revenue is estimated to be <$1M.

What is NeuroEM Therapeutics Inc.'s NAICS code?

Minus sign iconPlus sign icon
NeuroEM Therapeutics Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does NeuroEM Therapeutics Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, NeuroEM Therapeutics Inc. has approximately 6 employees across 1 continents, including North America. Key team members include Chief Executive Officer: G. A.Alzheimer's Community Advocate & Investor: P. M.. Explore NeuroEM Therapeutics Inc.'s employee directory with LeadIQ.

What industry does NeuroEM Therapeutics Inc. belong to?

Minus sign iconPlus sign icon
NeuroEM Therapeutics Inc. operates in the Medical Devices industry.

What technology does NeuroEM Therapeutics Inc. use?

Minus sign iconPlus sign icon
NeuroEM Therapeutics Inc.'s tech stack includes Open GraphSquarespaceSquarespace CommerceFont AwesomeModernizrparallax.jsGoogle Tag ManagerAdobe Fonts.

What is NeuroEM Therapeutics Inc.'s email format?

Minus sign iconPlus sign icon
NeuroEM Therapeutics Inc.'s email format typically follows the pattern of First.Last@neuroem.com. Find more NeuroEM Therapeutics Inc. email formats with LeadIQ.

When was NeuroEM Therapeutics Inc. founded?

Minus sign iconPlus sign icon
NeuroEM Therapeutics Inc. was founded in 2013.
NeuroEM Therapeutics Inc. logo

NeuroEM Therapeutics Inc.

Medical DevicesArizona, United States2-10 Employees

NeuroEM Therapeutics Inc. is a medical device company based in Phoenix, Arizona, focused on developing and clinically testing Transcranial Electromagnetic Treatment (TEMT) for Alzheimer’s disease and other neurodegenerative conditions. Its MemorEM head-cap device is designed to be worn during in-home treatment and aims to target brain pathology by delivering TEMT to disaggregate toxic protein oligomers within neurons, a process associated with the progression of memory impairment. The company positions its technology as a non-invasive approach that could potentially prevent, halt, or reverse aspects of cognitive decline, with products intended for use under professional supervision once regulatory approval is obtained. NeuroEM operates within the medical equipment manufacturing industry, targeting neurologists and other health professionals who diagnose memory disorders as its primary customers, and it emphasizes a move from clinical testing toward broader clinical adoption pending regulatory milestones. The firm has pursued narrative progress through public statements and recent news highlighting recognition and clinical development related to its device and therapeutic approach.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • <$1M

    NeuroEM Therapeutics Inc.'s revenue is estimated to be in the range of <$1M

Section iconFunding & Financials

  • <$1M

    NeuroEM Therapeutics Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.